Auxilium, the Worcester accelerator backed by Rucker Investments, is partnering with Massachusetts Biomedical Initiatives to bring in a new cohort of biotech and life science companies.
Risk-averse investors might want to look elsewhere. For others, though, holding on doesn’t seem like a bad idea.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results